HRC promotes anoikis resistance and metastasis by suppressing endoplasmic reticulum stress in hepatocellular carcinoma

Int J Med Sci. 2021 Jun 26;18(14):3112-3124. doi: 10.7150/ijms.60610. eCollection 2021.

Abstract

Histidine-rich calcium binding protein (HRC) is markedly overexpressed in hepatocellular carcinoma (HCC) and is significantly correlated with metastasis. Anoikis resistance and endoplasmic reticulum (ER) stress may have a critical effect on survival before metastasis. However, the potential functions of HRC in anoikis resistance in HCC remain unknown. Here, we uncovered the clinical value of HRC and its functional significance on anoikis in HCC. The positive expression of HRC was observably correlated with tumor size, tumor encapsulation, and tumor-node-metastasis (TNM) stage. The expression of HRC increased in HCC cells cultured in suspension. HRC enhanced the anoikis resistance of HCC, and promoted the HCC metastasis in vivo. Mechanistically, the anoikis resistance was probably dependent on endoplasmic reticulum stress. Modulating HRC level changed the ERS to affect anoikis resistance by acting protein kinase RNA-like ER kinase (PERK)-eIF2a-ATF4-CHOP signaling axis. In conclusion, we define HRC as a novel candidate oncogene involved in anoikis resistance and HCC metastasis, and provide a new potential therapeutic target for HCC.

Keywords: HRC; anoikis resistance; endoplasmic reticulum stress; hepatocellular carcinoma; metastasis.

Publication types

  • Observational Study

MeSH terms

  • Activating Transcription Factor 4 / metabolism
  • Adult
  • Anoikis
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Calcium-Binding Proteins / antagonists & inhibitors
  • Calcium-Binding Proteins / metabolism*
  • Carcinoma, Hepatocellular / diagnosis
  • Carcinoma, Hepatocellular / drug therapy
  • Carcinoma, Hepatocellular / pathology*
  • Cell Line, Tumor
  • Disease Progression
  • Endoplasmic Reticulum Stress / drug effects
  • Female
  • Humans
  • Liver / pathology
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / pathology*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Signal Transduction / drug effects
  • Transcription Factor CHOP / metabolism
  • Xenograft Model Antitumor Assays
  • eIF-2 Kinase / metabolism

Substances

  • ATF4 protein, human
  • Antineoplastic Agents
  • Calcium-Binding Proteins
  • DDIT3 protein, human
  • HRC protein, human
  • Activating Transcription Factor 4
  • Transcription Factor CHOP
  • EIF2AK3 protein, human
  • eIF-2 Kinase